The role of miR-150 in normal and malignant hematopoiesis

Oncogene

Volumn 33, Issue 30, 2014, Pages 3887-3893

  He, Y ^a   Jiang, X ^a   Chen, J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 150; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; BIOLOGICAL FUNCTIONS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; INJURY; LYMPHOMA; MANTLE CELL LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SYSTEMATIC REVIEW (TOPIC);

ANIMALS; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HUMANS; LEUKEMIA; LYMPHOMA; MICRORNAS; MYELODYSPLASTIC SYNDROMES; RNA INTERFERENCE;

EID: 84905054904     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.346     Document Type: Review

References (67)

1. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233
2. Siomi H, Siomi MC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 2010; 38: 323-332
3. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531 (Pubitemid 38868508)
4. Xiao C, Rajewsky K. MicroRNA control in the immune system: Basic principles. Cell 2009; 136: 26-36
5. Newman MA, Hammond SM. Emerging paradigms of regulated microRNA processing. Genes Dev 2010; 24: 1086-1092
6. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86 (Pubitemid 38055775)
7. Orkin SH, Zon LI. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008; 132: 631-644 (Pubitemid 351260057)
8. Rowley JD. Chromosomal translocations: Revisited yet again. Blood 2008; 112: 2183-2189
9. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079-1089
10. Mullighan CG, Downing JR. Global genomic characterization of acute lymphoblastic leukemia. Semin Hematol 2009; 46: 3-15
11. Ntziachristos P, Mullenders J, Trimarchi T, Aifantis I. Mechanisms of epigenetic regulation of leukemia onset and progression. Adv Immunol 2013; 117: 1-38
12. Chen J, Odenike O, Rowley JD. Leukaemogenesis: More than mutant genes. Nat Rev Cancer 2010; 10: 23-36
13. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008; 15: 352-358
14. Marcucci G, Radmacher MD, Mrozek K, Bloomfield CD. MicroRNA expression in acute myeloid leukemia. Curr Hematol Malig Rep 2009; 4: 83-88
15. Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 2011; 117: 1121-1129
16. Lawrie CH. MicroRNAs and lymphomagenesis: A functional review. Br J Haematol 2013; 160: 571-581
17. Fang J, Varney M, Starczynowski DT. Implication of microRNAs in the pathogenesis of MDS. Curr Pharm Des 2012; 18: 3170-3179
18. Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai TH et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005; 6: R71
19. Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol 2004; 5: 721-729 (Pubitemid 39023304)
20. Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005; 23: 275-286 (Pubitemid 41317795)
21. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-159 (Pubitemid 47498525)
22. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080-7085 (Pubitemid 47186012)
23. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S et al. Modulation of microRNA expression in human T-cell development: Targeting of NOTCH3 by miR-150. Blood 2011; 117: 7053-7062
24. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91: 661-672 (Pubitemid 27513657)
25. Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. J Exp Med 2011; 208: 2717-2731
26. Zheng Q, Zhou L, Mi QS. MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function. J Immunol 2012; 188: 2118-2126
27. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on Distinct threshold levels of c-Myb. EMBO J 2003; 22: 4478-4488 (Pubitemid 37087201)
28. Vegiopoulos A, Garcia P, Emambokus N, Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006; 107: 4703-4710 (Pubitemid 43882618)
29. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007; 35: 1657-1667 (Pubitemid 47633777)
30. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008; 14: 843-853 (Pubitemid 351757199)
31. Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol 2008; 36: 1585-1592
32. Wang Y, Probin V, Zhou D. Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy. Curr Cancer Ther Rev 2006; 2: 271-279 (Pubitemid 44203363)
33. Adams BD, Guo S, Bai H, Guo Y, Megyola CM, Cheng J et al. An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response. Cell Rep 2012; 2: 1048-1060
34. Hussein K, Theophile K, Busche G, Schlegelberger B, Gohring G, Kreipe H et al. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010; 34: 328-334
35. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007; 109: 4944-4951 (Pubitemid 46827793)
36. Moussay E, Wang K, Cho JH, van Moer K, Pierson S, Paggetti J et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2011; 108: 6573-6578
37. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: Proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008; 215: 13-20 (Pubitemid 351619871)
38. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, Cordeu L et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34 cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6: 1830-1840
39. Machova Polakova K, Lopotova T, Klamova H, Burda P, Trneny M, Stopka T et al. Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer 2011; 10: 41
40. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007; 40: 1435-1440 (Pubitemid 350302855)
41. Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van Der Velden VH et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009; 23: 313-322
42. Wang Y, Li Z, He C, Wang D, Yuan X, Chen J et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis 2010; 44: 191-197
43. Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 2009; 4: E7826
44. Xu L, Liang YN, Luo XQ, Liu XD, Guo HX. Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi 2011; 32: 178-181
45. Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-Associated leukemia. Cancer Cell 2012; 22: 524-535
46. Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med 2013; 11: 31
47. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 87: 2870-2877 (Pubitemid 26102237)
48. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7: 823-833 (Pubitemid 350006257)
49. Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van Den Heuvel-Eibrink M et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009; 113: 2375-2385
50. Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U et al. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol 2004; 24: 617-628 (Pubitemid 38057914)
51. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009; 113: 3314-3322
52. Mi S, Li Z, Chen P, He C, Cao D, Elkahloun A et al. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci USA 2010; 107: 3710-3715
53. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S et al. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun 2012; 2: 688
54. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 2009; 106: 3384-3389
55. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43-50
56. Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated selfrenewal program as essential for leukemia maintenance. Genes Dev 2011; 25: 1628-1640
57. Bousquet M, Zhuang G, Meng C, Ying W, Cheruku PS, Shie AT et al. MiR-150 blocks MLL-AF9 associated leukemia by repressing multiple oncogenes. Mol Cancer Res. (e-pub ahead of print 19 April 2013; doi:10.1158/1541-7786.MCR-13-0002-T
58. Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010; 115: 2630-2639
59. Cai J, Liu X, Cheng J, Li Y, Huang X, Ma X et al. MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. Graefes Arch Clin Exp Ophthalmol 2012; 250: 523-531
60. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T et al. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009; 11: 167-176
61. Chen S, Wang Z, Dai X, Pan J, Ge J, Han X et al. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro. Cancer Sci 2013; 104: 826-834
62. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011; 25: 1324-1334
63. Guo Y, Niu C, Breslin P, Tang M, Zhang S, Wei W et al. c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Blood 2009; 114: 2097-2106
64. Jiang X, Chen J. miR-150:targeting MLL leukemia. Oncotarget 2012; 3: 1268-1269
65. Muntean AG, Hess JL. The pathogenesis of mixed-lineage leukemia. Annu Rev Pathol 2012; 7: 283-301
66. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436: 807-811 (Pubitemid 41160633)
67. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev 1998; 12: 1769-1774. (Pubitemid 28304329)